Literature DB >> 23224743

Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.

Lingling Geng1, Jian Gao, Wei Cui, Yancheng Tang, Mingjuan Ji, Bozhen Chen.   

Abstract

In this work, selectivity mechanism of APP-IP inhibitor (β-amyloid precursor protein-derived inhibitory peptide) over matrix metalloproteinases (MMPs including MMP-2, MMP-7, MMP-9 and MMP-14) was investigated by molecular modeling methods. Among MMPs, MMP-2 is the most favorable one for APP-IP interacting based on our calculations. The predicted binding affinities can give a good explanation of the activity difference of inhibitor APP-IP. In Comparison with MMP-2/APP-IP complex, the side chain of Tyr214(MMP-7) makes the binding pocket so shallow that the whole side chain of Tyr3(APP-IP) can not be fully embraced, thus unfavorable for the N-terminal of APP-IP binding to MMP-7. The poor selectivity of APP-IP toward MMP-9 is mainly related with the decrease of interaction between the APP-IP C-terminal and MMP-9 due to the bulky side chains of Pro193 and Gln199, which is in agreement with experiment. The mutations at residues P193A and Q199G of MMP-9 alternate the binding pattern of the C-terminal of APP-IP by forming two new hydrogen bonds and hydrophobic interactions with MMP-9. The mutants favor the binding affinity of MMP-9 largely. For MMP-14/APP-IP, the large steric effect of Phe204(MMP-14) and the weak contributions of the polar residues Asn231(MMP-14) and Thr190(MMP-14) could explain why MMP-14 is non-selective for APP-IP interacting. Here, the molecular modeling methods were successfully employed to explore the selective inhibitor of MMPs, and our work gives valuable information for future rational design of selective peptide inhibitors toward individual MMP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224743     DOI: 10.1007/s10822-012-9617-3

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  37 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.

Authors:  Holger Gohlke; Christina Kiel; David A Case
Journal:  J Mol Biol       Date:  2003-07-18       Impact factor: 5.469

Review 3.  The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases.

Authors:  A J Docherty; J O'Connell; T Crabbe; S Angal; G Murphy
Journal:  Trends Biotechnol       Date:  1992-06       Impact factor: 19.536

4.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

5.  Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.

Authors:  Tingjun Hou; Wei Zhang; David A Case; Wei Wang
Journal:  J Mol Biol       Date:  2008-01-03       Impact factor: 5.469

6.  Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.

Authors:  Shouichi Higashi; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

7.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.

Authors:  Shouichi Higashi; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2008-01-31       Impact factor: 5.157

9.  TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.

Authors:  A Amour; P M Slocombe; A Webster; M Butler; C G Knight; B J Smith; P E Stephens; C Shelley; M Hutton; V Knäuper; A J Docherty; G Murphy
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

View more
  3 in total

1.  Exploring the binding mechanisms of diaminopimelic acid analogs to meso-diaminopimelate dehydrogenase by molecular modeling.

Authors:  Huiqun Wang; Glen E Kellogg; Ping Xu; Yan Zhang
Journal:  J Mol Graph Model       Date:  2018-06-02       Impact factor: 2.518

2.  HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery.

Authors:  Lingling Geng; Zihua Wang; Xiangqian Jia; Qiuju Han; Zhichu Xiang; Dan Li; Xiaoliang Yang; Di Zhang; Xiangli Bu; Weizhi Wang; Zhiyuan Hu; Qiaojun Fang
Journal:  Theranostics       Date:  2016-05-28       Impact factor: 11.556

3.  Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors.

Authors:  Lingling Geng; Zihua Wang; Xiaoliang Yang; Dan Li; Wenxi Lian; Zhichu Xiang; Weizhi Wang; Xiangli Bu; Wenjia Lai; Zhiyuan Hu; Qiaojun Fang
Journal:  Theranostics       Date:  2015-08-01       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.